Skip to main content
. Author manuscript; available in PMC: 2020 Dec 7.
Published in final edited form as: Sci Transl Med. 2019 Nov 13;11(518):eaax9000. doi: 10.1126/scitranslmed.aax9000

Fig. 6. Estimation of pathogen burden among patients stratified into three PERSEVERE II–based mortality risk strata.

Fig. 6.

Patients were grouped into one of three PERSEVERE II–based mortality risk strata: low risk (n = 286; mortality risk, 0.000 to 0.019), intermediate risk (n = 106; mortality risk, 0.167 to 0.189), and high risk (n = 69; mortality risk, 0.300 to 0.571). (A) Proportion of patients in each risk stratum having any positive pathogen culture from any normally sterile site (P < 0.05, χ2 test, two degrees of freedom). (B) Among patients with positive cultures, proportion of patients in each risk stratum having a positive blood culture (P < 0.05, χ2 test, two degrees of freedom).